Navidea BiopharmaceuticalsNAVB 
$0.000.00%24h
0.00%24h
Global rank
Market cap$100.08K
Change 7d0.00%
YTD Performance-98.16%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Navidea Biopharmaceuticals (NAVB)
As of November 2024, Navidea Biopharmaceuticals has a market cap of $100.08K. This makes Navidea Biopharmaceuticals the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Navidea Biopharmaceuticals from 1992 to 2024
-
Value:-
Market cap history of Navidea Biopharmaceuticals from 1992 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $4.75M | -13.95% |
| 2023 | $5.52M | -73.71% |
| 2022 | $21.02M | -79.00% |
| 2021 | $100.08M | -53.49% |
| 2020 | $215.18M | 70.63% |
| 2019 | $126.11M | -37.00% |
| 2018 | $200.17M | -72.22% |
| 2017 | $720.60M | -43.75% |
| 2016 | $1.28B | -51.88% |
| 2015 | $2.66B | -29.63% |
| 2014 | $3.78B | -8.70% |
| 2013 | $4.14B | -26.86% |
| 2012 | $5.66B | 8.02% |
| 2011 | $5.24B | 27.18% |
| 2010 | $4.12B | 68.85% |
| 2009 | $2.44B | 114.04% |
| 2008 | $1.14B | 96.55% |
| 2007 | $580.49M | 20.83% |
| 2006 | $480.40M | -4.00% |
| 2005 | $500.42M | -57.63% |
| 2004 | $1.18B | 90.32% |
| 2003 | $620.52M | 138.46% |
| 2002 | $260.22M | -69.05% |
| 2001 | $840.71M | -0.44% |
| 2000 | $844.46M | -3.57% |
| 1999 | $875.74M | -39.13% |
| 1998 | $1.44B | -88.02% |
| 1997 | $12.01B | -60.98% |
| 1996 | $30.78B | -4.65% |
| 1995 | $32.28B | 975.00% |
| 1994 | $3.00B | -76.00% |
| 1993 | $12.51B | 4.17% |
| 1992 | $12.01B | - |
NAVB Market Cap Today is $100.08K 0.00% - 8 Nov 2024
View largest stocks by market cap 
